Literature DB >> 9891508

Status of the p53, Rb and MDM2 genes in canine osteosarcoma.

S Mendoza1, T Konishi, W S Dernell, S J Withrow, C W Miller.   

Abstract

The key role of p53 and Rb alterations in human osteosarcoma is clear. For example, osteosarcoma is common in individuals inheriting mutant p53 or Rb genes. Osteosarcoma in dogs is similar to humans by histology, site, gender ratio and several other biological parameters. To study whether this similarity extends to the molecular level, 21 canine osteosarcomas were analyzed for alterations of p53, Rb and MDM2. MDM2 is a normal cell protein which antagonizes p53, amplification is seen in some human sarcomas. The gross structure of the p53, Rb and MDM2 genes was examined by Southern blotting. No deletions or rearrangements of the p53 or Rb genes were detected. The absence of gross gene alterations affecting these tumor suppressor genes is a significant difference between the disease in dogs and humans, since rearrangements or deletions of the p53 or Rb genes occur in 20-30 per cent of human osteosarcomas. The MDM2 gene appeared to be duplicated in one canine tumor but no cases of significant amplification were detected. Expression of normal Rb was detected in all cases. Mutations of the p53 gene were found in 38 percent of canine osteosarcomas. Analysis of mutations revealed a predominance of spontaneous mutation. These finding emphasize the key role that alterations of p53 have in the development of osteosarcoma in dogs and humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9891508

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  16 in total

1.  Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression.

Authors:  Melissa Paoloni; Sean Davis; Susan Lana; Stephen Withrow; Luca Sangiorgi; Piero Picci; Stephen Hewitt; Timothy Triche; Paul Meltzer; Chand Khanna
Journal:  BMC Genomics       Date:  2009-12-23       Impact factor: 3.969

2.  Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors.

Authors:  C M Cannon; J Pozniak; M C Scott; D Ito; B H Gorden; A J Graef; J F Modiano
Journal:  Vet Comp Oncol       Date:  2013-02-15       Impact factor: 2.613

3.  A pRb-responsive, RGD-modified, and hyaluronidase-armed canine oncolytic adenovirus for application in veterinary oncology.

Authors:  Eduardo Laborda; Cristina Puig-Saus; Alba Rodriguez-García; Rafael Moreno; Manel Cascalló; Josep Pastor; Ramon Alemany
Journal:  Mol Ther       Date:  2014-01-22       Impact factor: 11.454

4.  Identification of Differentially Expressed Genes under the Regulation of Transcription Factors in Osteosarcoma.

Authors:  Yang Liu; Jianzhong Guan; Xiaotian Chen
Journal:  Pathol Oncol Res       Date:  2018-11-08       Impact factor: 3.201

Review 5.  TP53 in bone and soft tissue sarcomas.

Authors:  Elizabeth Thoenen; Amanda Curl; Tomoo Iwakuma
Journal:  Pharmacol Ther       Date:  2019-07-02       Impact factor: 12.310

6.  Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma.

Authors:  Jaime F Modiano; Matthew Breen; Rachael Thomas; Huixia J Wang; Pei-Chien Tsai; Cordelia F Langford; Susan P Fosmire; Cristan M Jubala; David M Getzy; Gary R Cutter
Journal:  Chromosome Res       Date:  2009-04-01       Impact factor: 5.239

7.  Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.

Authors:  Laura Bongiovanni; Francesca Mazzocchetti; Daniela Malatesta; Mariarita Romanucci; Andrea Ciccarelli; Paolo Buracco; Raffaella De Maria; Chiara Palmieri; Marina Martano; Emanuela Morello; Lorella Maniscalco; Leonardo Della Salda
Journal:  BMC Vet Res       Date:  2012-06-11       Impact factor: 2.741

8.  The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.

Authors:  Stacey L Fossey; Misty D Bear; Jiayuh Lin; Chenglong Li; Eric B Schwartz; Pui-Kai Li; James R Fuchs; Joelle Fenger; William C Kisseberth; Cheryl A London
Journal:  BMC Cancer       Date:  2011-03-28       Impact factor: 4.430

9.  Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.

Authors:  Gayathri T Selvarajah; Jolle Kirpensteijn; Monique E van Wolferen; Nagesha A S Rao; Hille Fieten; Jan A Mol
Journal:  Mol Cancer       Date:  2009-09-07       Impact factor: 27.401

10.  Breed-predispositions to cancer in pedigree dogs.

Authors:  Jane M Dobson
Journal:  ISRN Vet Sci       Date:  2013-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.